Nea Management Company, LLC Reneo Pharmaceuticals, Inc. Put Options Transaction History
Nea Management Company, LLC
- $1.43 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RPHM
# of Institutions
67Shares Held
29.4MCall Options Held
125KPut Options Held
3.1K-
Tang Capital Management LLC San Diego, CA3MShares$4.5 Million0.61% of portfolio
-
Highbridge Capital Management LLC New York, NY2.74MShares$4.1 Million1.03% of portfolio
-
Carlyle Group Inc. Washington, DC2.7MShares$4.05 Million0.33% of portfolio
-
River Vest Venture Management LLC St. Louis, MO2.53MShares$3.8 Million51.67% of portfolio
-
Octagon Capital Advisors LP New York, NY2.25MShares$3.38 Million0.58% of portfolio
About Reneo Pharmaceuticals, Inc.
- Ticker RPHM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,479,600
- Market Cap $36.7M
- Description
- Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...